Optimizing MOAs of JAK Inhibitors in a 36-Year-Old Male With a History of Atopic Dermatitis

Jayme Heim, MSN, FNP-BC, explores strategies for optimizing the mechanisms of action of topical JAK inhibitors in treating a 36-year-old male patient with a history of atopic dermatitis, highlighting the potential benefits and considerations of this therapeutic approach.